PCOS weight loss: myo-inositol vs metformin – which works better?

NCT ID NCT07387679

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared myo-inositol and metformin for helping women with polycystic ovary syndrome (PCOS) lose weight. Sixty women took either myo-inositol or metformin for three months. The main goal was to see which drug reduced body mass index (BMI) more effectively.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

myo-inositol and metformin

What this could lead to

If myo-inositol works as well as metformin, it could offer a gentler option for managing weight in PCOS.

What could go wrong

This is a small, completed trial with only 60 participants. Results may not apply to everyone, and neither drug is a cure—weight management may need ongoing treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARIAN SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

polycystic ovary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bahwal Victoria Hospital

    Bahawalpur, Punjab Province, 63100, Pakistan